BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
University College London
Londres, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von University College London (8)
2019
-
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
Leukemia, Vol. 33, Núm. 9, pp. 2254-2265
-
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
Leukemia, Vol. 33, Núm. 9, pp. 2241-2253
2016
-
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): A multi-institutional retrospective study
British Journal of Haematology, Vol. 172, Núm. 5, pp. 709-715
-
Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia
Blood, Vol. 128, Núm. 10, pp. 1321-1328
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477
-
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus
Blood, Vol. 124, Núm. 9, pp. 1404-1411
2007
-
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936
Leukemia, Vol. 21, Núm. 2, pp. 215-221